CTNNB1 and hepatocellular carcinoma: According to existing papers, mutation of CTNNB1, remarkably characterizing the immune-excluded phenotype, could serve as a novel indicator for prediction of immunotherapeutic resistance in HCC (Pinyol et al., 2019).